Noninvasive prenatal testing for aneuploidy using cell-free DNA – New implications for maternal health

Abstract excerpt

The rapid global uptake of noninvasive prenatal testing for Down syndrome based on maternal plasma cell-free DNA has provided new data on the interrelationship between cell-free DNA and maternal health. Specific maternal conditions that can affect the performance of noninvasive prenatal testing include obesity, active autoimmune disease and low molecular weight heparin treatment. There is also a growing...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Prenatal Screening and Diagnostics
• Share to Renal and related cancers
• Share to Tumors and Oncological Cases